Compounds for the treatment of spinal muscular atrophy and other uses

Details for Australian Patent Application No. 2007227398 (hide)

Owner Albany Molecular Research, Inc. The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Johnson, Graham; Heemskerk, Jill; Johnson, Matthew Robert; McCall, John M.; Barnes, Keith D.; Fairfax, David

Agent Fisher Adams Kelly

Pub. Number AU-B-2007227398

PCT Pub. Number WO2007/109211

Priority 60/783,292 17.03.06 US

Filing date 16 March 2007

Wipo publication date 27 September 2007

Acceptance publication date 27 September 2012

International Classifications

C07D 209/46 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/109211 Priority application(s): WO2007/109211

27 November 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read from 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses To: Compounds for the treatment of spinal muscular atrophy and other uses

27 November 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name Albany Molecular Research, Inc.; Science Applications International Corporation (SAIC) and Government Of The United States of America, Represented by the Secretary, Department of Health and Human Services, Application No. 2007227398, under INID (22), correct the filing date of the application to 16 March 2007

6 September 2012 Assignment before Grant

  Government Of The United States of America, Represented by the Secretary, Department of Health and Human Services; Science Applications International Corporation (SAIC); Albany Molecular Research, Inc. The application has been assigned to Government Of The United States of America, Represented by the Secretary, Department of Health and Human Services; Albany Molecular Research, Inc. Assignments before Grant, Section 113

20 September 2012 Alteration of Name

  The name of the applicant has been altered to Albany Molecular Research, Inc.; The United States of America, as represented by the Secretary, Department of Health and Human Services

27 September 2012 Application Accepted

  Published as AU-B-2007227398

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007227404-Compounds from an extract of Artemisia and methods for treating disorders

2007227397-Extracts and methods comprising curcuma species